Roszdravnadzor Denies Shortage of 'Atarax' and Other Hydroxyzine Drugs
- Published:
- First detected:
Insights by Echo AI
Roszdravnadzor has refuted claims of a shortage of the prescription sedative drug 'Atarax' and other drugs based on hydroxyzine in Russia. According to the agency, more than 1.06 million packages of these drugs are currently in civilian circulation, with no signs of a shortage. The agency also confirmed that there are sufficient supplies of these drugs in Moscow and St. Petersburg, contradicting earlier media reports.
Source coverage
7
records merged
0
0 unique
4
4 unique
3
3 unique
7 Sources
"Атаракс" и другие препараты на основе гидроксизина регулярно вводятся...
Росздравнадзор отрицает дефицит препарата "Атаракс" Признаков дефицита...
Более 500 тысяч упаковок «Атаракса» сейчас в гражданском обороте в Рос...
Росздравнадзор опроверг дефицит препаратов от тревоги "Атаракс". Более...
Unlock Echo Intelligence
Move beyond the public feed. Monitor breaking stories across Telegram, X, and the web — with earlier visibility, clearer context, and complete control over your sources.
- Monitor Telegram, X, and web in one place
- Add any source, from niche channels to global outlets
- Build custom feeds around events, regions, entities, or keywords
- Merge duplicate coverage into one clear, source-transparent story
- Auto-translate summaries and full articles
- Search past coverage and use AI-powered editorial tools
